I’ve been looking at DBS (SGX: D05) recently. It’s a classic "boring but brilliant" story. While the current price action might look shaky to the uninitiated, for long-term investors, this recent pullback isn't a signal to panic; it's an opportunity to accumulate. Here is my professional breakdown of why DBS remains a core holding and a prime candidate for Dollar-Cost Averaging (DCA) right now. 1. The "Falling Knife" vs. The "Blue-Chip Sale" Yes, the stock is currently falling. But we need to differentiate between structural decline and profit-taking/correction. · Context is key: In many cases, when a blue chip of this caliber drops, it’s usually due to macro headwinds (interest rate speculation, global economic fears) rather than a deterioration of the business itself. · The Opportunity:
I’ve been looking at DBS (SGX: D05) recently. It’s a classic "boring but brilliant" story. While the current price action might look shaky to the uninitiated, for long-term investors, this recent pullback isn't a signal to panic; it's an opportunity to accumulate. Here is my professional breakdown of why DBS remains a core holding and a prime candidate for Dollar-Cost Averaging (DCA) right now. 1. The "Falling Knife" vs. The "Blue-Chip Sale" Yes, the stock is currently falling. But we need to differentiate between structural decline and profit-taking/correction. · Context is key: In many cases, when a blue chip of this caliber drops, it’s usually due to macro headwinds (interest rate speculation, global economic fears) rather than a deterioration of the business itself. · The Opportunity: